ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Synovitis"

  • Abstract Number: 0501 • ACR Convergence 2022

    Single-molecule Spatial Transcriptomic Analysis Reveals Distinct Cellular Networks in Rheumatoid Arthritis Synovia

    Roopa Madhu1, Kartik Bhamidipati1, Nghia Millard2, Michelle Curtis2, Ye Cui3, Youngmi Kim3, Ellen Gravallese4, Soumya Raychaudhuri1, Michael Brenner4, ilya Korsunsky1 and Kevin Wei5, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Boston, MA, 3Nanostring Technologies Inc., Seattle, WA, 4Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 5Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Chronic joint inflammation in rheumatoid arthritis (RA) arises from the interactions of many cell types. Single-cell transcriptomic profiling of RA joints has identified novel…
  • Abstract Number: 2166 • ACR Convergence 2022

    Inflammatory Arthritis in an Australian Scleroderma Cohort – Patient Characteristics, Associations and Treatments

    Eric Schwender1, Dylan Hansen2, Wendy Stevens2, Laura Ross3, Nava Ferdowsi2, Susanna Proudman4, Jenny Walker5, Jo Sahhar6, Gene-Siew Ngian7, Lauren Host8, Gabor Major9, Mandana Nikpour10 and Kathleen Morrisroe2, 1Royal College of Surgeons, Dublin, Ireland, 2St Vincent's Hospital Melbourne, Melbourne, Australia, 3The University of Melbourne at St. Vincent's Hospital, Brunswick, Australia, 4Rheumatology Unit, Royal Adelaide Hospital, and Discipline of Medicine, University of Adelaide, Adelaide, Australia, 5Royal Adelaide Hospital, Adelaide, Australia, 6Monash Health, Melbourne, Australia, 7Melbourne Health, Northcote, Australia, 8Fiona Stanley Hospital, London, United Kingdom, 9Hunter New England Health Service, Rankin Park - Newcastle, New South Wales, Australia, 10The University of Melbourne at St. Vincent's Hospital Melbourne, Melbourne, Australia

    Background/Purpose: To characterise a cohort of Australian scleroderma patients with inflammatory arthritis including patient characteristics, autoantibody profile, therapy and impact on function and quality of…
  • Abstract Number: 0554 • ACR Convergence 2022

    Loss of Synovial Tissue Macrophage Homeostasis Precedes Rheumatoid Arthritis Clinical Onset

    Megan Hanlon1, Mary Canavan2, conor Smith3, Achilleas Floudas4, Nuno Neto5, Qingxuan Song6, Phil Gallagher7, Ronan Mullan8, Conor Hurson9, Barry Moran5, Michael Monaghan5, Sunil Nagpal10, Douglas Veale11 and Ursula Fearon5, 1Molecular Rheumatology, Dublin, Ireland, 2Trinity College, Dublin, Ireland, 3bTrinity College Dublin, Dublin, Ireland, 4Molecular Rheumatology Trinity Biomedical Sciences Institute, Dublin, Ireland, 5Trinity College Dublin, Dublin, Ireland, 6Janssen Research and Development, LLC, Spring House, PA, 7St Vincent's University Hospital, Dublin, Ireland, 8Tallaght University Hospital, Dublin, Ireland, 9St Vincents University Hospital, Dublin, Ireland, 10Janssen Research, Collegeville, PA, 11St. Vincent's University Hospital, Blackrock, Dublin, Ireland

    Background/Purpose: Synovial-tissue macrophages significantly contribute to Rheumatoid Arthritis, yet the precise nature/function of macrophage subsets within the inflamed joint remains unexplored. Here we explore the…
  • Abstract Number: 0619 • ACR Convergence 2022

    Differences Between Patients in Remission with Active Rheumatoid Arthritis by Histological and Molecular Comparisons

    Selina Ohl1, Klaus Frommer2, Markus Rickert3, Stefan Rehart4, Ulf Müller-Ladner5 and Elena Neumann6, 1Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, 2Justus Liebig University Gießen, Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Bad Nauheim, Germany, 3Dept. of Orthopaedics and Orthopaedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany, Gießen, Germany, 4Agaplesion Markus Hospital, Dpt of Orthopaedics and Trauma Surgery, Frankfurt, Germany, 5JLU Campus KK, Bad Nauheim, Germany, 6JLU Gießen, Campus Kerckhoff, Bad Nauheim, Germany

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease, whose inflammatory processes in the synovium lead to the destruction of cartilage and bone. Although there…
  • Abstract Number: 0758 • ACR Convergence 2022

    Remitting Seronegative Symmetrical Synovitis with Pitting Edema (RS3PE)-like Syndrome After Immune Checkpoint Inhibition: A CanRIO Study

    Azin Rouhi1, Shahin Jamal2, Marie Hudson3, Janet Pope4, Janet Roberts5, Alexandra Ladouceur3, Sara Hewitt6 and Carrie Ye1, 1University of Alberta, Edmonton, AB, Canada, 2University of British Columbia, Vancouver, BC, Canada, 3McGill University, Montréal, QC, Canada, 4University of Western Ontario, London, ON, Canada, 5Dalhousie University, Halifax, NS, Canada, 6Western University, London, ON, Canada

    Background/Purpose: Immune checkpoint inhibitors (ICI) have shown great promise in the treatment of different malignancies. The use of ICIs has been associated with toxicities that…
  • Abstract Number: 0776 • ACR Convergence 2022

    Expert Clinical Management of Immune-related Inflammatory Arthritis: Results from a Multicenter International Expert Survey

    Sebastian Bruera1, Maria Suarez-Almazor2 and mar Riveiro-Barciela3, 1Baylor College of Medicine, Houston, TX, 2MD Anderson Cancer Center, Houston, TX, 3Hospital Universitari Vall d'Hebron, Barcelona, Spain

    Background/Purpose: The management of inflammatory arthritis related to immune-related adverse events (irAEs) from immune checkpoint inhibitors (ICI) is challenging. Arthritis can become chronic and require…
  • Abstract Number: 0803 • ACR Convergence 2022

    Performance of Adenosine Deaminase Activity in Sinovial Fluid for the Early Diagnosis of Tuberculous Arthritis: A Meta Analysis

    Juan Carlos Cortés-Quiroz1, Javier Ena2, José Antonio Bernal3 and José Rosas4, 1Marina Baixa Hospital, Mutxamel, Spain, 2Department of Internal Medicine. Marina Baixa Hospital, Villajoyosa, Spain, 3Rheumatology Department. Marina Baixa Hospital, Alicante, Spain, 4Rheumatology Department, Hospital Marina Baixa, Villajoyosa, Spain

    Background/Purpose: Adenosine deaminase (ADA) activity has shown good performance in diagnosing pleural, peritoneal, and meningeal tuberculosis. This study aimed to evaluate the performance of measuring…
  • Abstract Number: 1232 • ACR Convergence 2022

    Reliability and Validity of Single Axial Slice vs. Multiple Slice Quantitative Measurement of the Volume of Effusion-Synovitis on 3T Knee MRI in Knees with Osteoarthritis

    Greg Gilles1, Arjun Vohra1, Chelsea Caruso1, Dagoberto Robles1, Mihra Taljanovic1, Jeffrey Duryea2, Erin Ashbeck1, Edward Bedrick3 and Kent Kwoh4, 1University of Arizona Arthritis Center, Tucson, AZ, 2Brigham and Women's Hospital, Boston, MA, 3Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, 4University of Arizona, Tucson, AZ

    Background/Purpose: Effusion-synovitis (ES) on knee MRI has been identified as an important biomarker of OA. Semi-automated software methods offer objective measurements of ES volume on…
  • Abstract Number: 1389 • ACR Convergence 2022

    The New Serum Synovial Biochemical Marker HELIX-III Predicts Radiological Progression in Early Arthritis Independently of Usual Risk Factors

    Patrick Garnero1, Evelyne Gineyts1, Jean-Charles Rousseau1, Pascal Richette2, Jérémie SELLAM3 and Roland Chapurlat1, 1INSERM 1033, Lyon, France, 2Department of Rheumatology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Paris, France, 3Sorbonne Universite, AP-HP, Saint-Antoine hospital, Paris, France

    Background/Purpose: The prognosis of rheumatoid arthritis (RA) is highly variable across patients (P.) and difficult to predict. Usual risk factors, e.g., radiological joint damage, increased…
  • Abstract Number: 1680 • ACR Convergence 2022

    Module Signatures of Synovial Single-cell States Identify Disease Phenotypes in Early Treatment-naive Rheumatoid Arthritis

    Felice Rivellese1, Elena Pontarini2, Cankut Cubuk1, Alessandra Nerviani1, Liliane Fossati-Jimack1, Anna Surace1, Elisabetta Sciacca3, Katriona Goldmann1, Michele Bombardieri4, Myles Lewis1 and Costantino Pitzalis1, 1Queen Mary University of London, London, United Kingdom, 2William Harvey Research Institute, London, United Kingdom, 3Queen Mary University of London, Biancavilla, Italy, 4Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University, London, United Kingdom

    Background/Purpose: Despite extensive studies, the relationship between circulating and local immune cells and clinico-pathological features of Immune-Mediated Inflammatory Diseases remains unclear. Recently, synovium-specific cell states…
  • Abstract Number: 1360 • ACR Convergence 2021

    Ultrasound Demonstrates Continued Improvement in Psoriatic Arthritis Synovitis and Enthesitis with Secukinumab: 52-week Results from a Phase III Study

    Maria Antonietta D'Agostino1, Georg Schett2, Corine Gaillez3, Carlos Guerrero4, PETRA HANOVA5, Tomas Cazenave6, Maria S. Stoenoiu7, Marina Backhaus8, Gael Mouterde9, Maarten Boers10, Anne-Marie Duggan11, Punit Goyanka12 and Philip Conaghan13, 1Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, 2Universitätsklinikum Erlangen, Department of Internal Medicine 3 – Rheumatology and Immunology, Erlangen, Germany, Erlangen, Germany, 3Novartis Pharma AG, Basel, Switzerland, 4Dermatologico Country, Jalisco, Mexico, 5Department of Rheumatology, Institute of Rheumatology, Prague, Czech Republic, 6Instituto de Rehabilitación Psicofisica, Buenos Aires, Argentina, Buenos Aires, Argentina, 7Rheumatology department, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 8Department of Internal Medicine, Rheumatology and Clinical Immunology, Park-Klinik Weissensee Academic Hospital of the Charité, Berlin, Germany, Berlin, Germany, 9Rheumatology department, CHU Montpellier, Montpellier, France, 10Department of Epidemiology and Data Science, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 11Novartis Ireland Limited, Dublin, Ireland, Dublin, Ireland, 12Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India, 13Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Power Doppler ultrasound (PDUS) is a sensitive non-invasive imaging tool to visualize a wide range of articular and periarticular inflammation in psoriatic arthritis (PsA).1,2…
  • Abstract Number: 1522 • ACR Convergence 2021

    Potential Predictors of Persistence in Immune Check Point Inhibitor Induced Arthritis

    Anu Desai1, Lakshmi Priya Shadananan1, Adam Croft2, Lalit Pallan1, Neil Steven3 and Benjamin Fisher4, 1University of Birmingham, Birmingham, United Kingdom, 2University of Birmingham, Halesowen, United Kingdom, 3Institute of Immunology and Immunotherapy/University of Birmingham, Birmingham, United Kingdom, 4Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham; National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre and Department of Rheumatology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

    Background/Purpose: Immune Check Point Inhibitors (ICIs) are widely used in Oncology and are associated with multiple autoimmune and systemic inflammatory reactions called immune-related adverse events.…
  • Abstract Number: 0029 • ACR Convergence 2021

    JAK1 Regulates Autophagy and Reinforces the Inflammatory and Autoimmune Potentials in Rheumatoid Arthritis Synovial Fibroblasts

    Keita Ninagawa1, Masaru Kato1, Yuki Kudo2, Masaru Yoshimura2, Michihito Kono2, Yuichiro Fujieda1, Kenji Oku2 and Tatsuya Atsumi3, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 21. Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, 3Hokkaido University, Sapporo, Japan

    Background/Purpose: Rheumatoid arthritis (RA) is pathologically characterized by autoimmunity against citrullinated proteins, proliferative synovitis, and ultimately joint destruction. Synovial fibroblasts (SFs) are, when activated, capable…
  • Abstract Number: 1786 • ACR Convergence 2021

    Association of the Improvement of Synovitis and Enthesitis with Quality of Life/Patient Reported Outcomes in Patients with PsA Treated with Ixekizumab

    Lars Erik Kristensen1, Dennis McGonagle2, Martin Rudwaleit3, Hideto Kameda4, Thorsten Holzkaemper5, Celine El Baou6 and Josef Smolen7, 1Bispebjerg-Frederiksberg Hospital, Copenhagen,, Denmark, 2University of Leeds, Leeds, United Kingdom, 3Bielefeld University, Rheumatology, Klinikum Bielefeld, Berlin, Germany, 4Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University, Tokyo, Japan, 5Eli Lilly and Company, Bad Homburg, Germany, 6Eli Lilly and Company, Indianapolis, IN, 7Medical University of Vienna, Vienna, Austria

    Background/Purpose: PsA is an inflammatory rheumatic disease with manifestations including synovitis and enthesitis. During extensive study programs, IXE has shown a treatment effect across domains…
  • Abstract Number: 0060 • ACR Convergence 2021

    Lipidomic Profiling Identifies Different Expression of Oxylipins Between Synovial Tissue and Plasma of Patients with Rheumatoid and Psoriatic Arthritis

    Abha Singh1, Jessica Murillo Saich2, Roxana Coras3, Julio Ramirez4, Eric Chang2, Raquel Celis5, Aaron Armando2, Oswald Quehenberger2, Arthur Kavanaugh2, Juan D Cañete6 and Monica Guma7, 1University of California San Diego, San Diego, CA, 2University of California San Diego, La Jolla, CA, 3University of California San Diego/Department of Medicine, Autonomous University of Barcelona, San Diego, CA, 4Arthritis Unit, Rheumatology Department, Hospital Clinic and IDIBAPS, Barcelona, Spain, 5Hospital Clinic and IDIBAPS, Barcelona, Spain, 6Rheumatology Department, Hospital Clinic, Barcelona, Spain, 7University of California San Diego/San Diego VA Healthcare Service/Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

    Background/Purpose: Oxylipins are bioactive lipids derived from polyunsaturated fatty acids (PUFAs) that modulate inflammation. Oxylipins derived from n-6 PUFA precursors, such as arachidonic acid (AA),…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology